Optimization of a Photoretinoscopy Method for Determining the Objective Refraction of Children - Trial NCT06295536
Access comprehensive clinical trial information for NCT06295536 through Pure Global AI's free database. This phase not specified trial is sponsored by Essilor International and is currently Not yet recruiting. The study focuses on Ametropia. Target enrollment is 115 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Essilor International
Timeline & Enrollment
N/A
Mar 01, 2024
Aug 01, 2024
Primary Outcome
Objective refractive error
Summary
The objective is to compare the refractive parameters of the photorefraction prototype device
 without cycloplegia with the refractive parameters of reference device, an autorefractometer
 with and without cycloplegia.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06295536
Device Trial